Adicet Bio, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adicet Bio, Inc. stock issued during period, value, new issues for the quarter ending 2019-03-31 was $46.59M, a 47.87% decline year-over-year.
- Adicet Bio, Inc. stock issued during period, value, new issues for the quarter ending 2018-03-31 was $89.37M.
- Adicet Bio, Inc. stock issued during period, value, new issues for fiscal 2021 was $238.00M.
- Adicet Bio, Inc. stock issued during period, value, new issues for fiscal 2018 was $89.37M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $238.00M 10-K · filed 2023-03-15 | |
| 2019-03-31 | $46.59M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $89.37M 10-K · filed 2019-03-18 | |
| 2018-03-31 | $89.37M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |